1. Home
  2. ABEO vs DRDB Comparison

ABEO vs DRDB Comparison

Compare ABEO & DRDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$7.07

Market Cap

399.5M

Sector

Health Care

ML Signal

HOLD

DRDB

Roman DBDR Acquisition Corp. II Ordinary shares

N/A

Current Price

$10.57

Market Cap

320.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ABEO
DRDB
Founded
1974
2024
Country
United States
United States
Employees
226
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
399.5M
320.5M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
ABEO
DRDB
Price
$7.07
$10.57
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
1.6M
86.9K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
165.16
N/A
EPS
N/A
N/A
Revenue
$2,998,000.00
N/A
Revenue This Year
$1,024.31
N/A
Revenue Next Year
$145.42
N/A
P/E Ratio
N/A
$597.54
Revenue Growth
258.18
N/A
52 Week Low
$4.00
$10.25
52 Week High
$7.54
$10.58

Technical Indicators

Market Signals
Indicator
ABEO
DRDB
Relative Strength Index (RSI) 73.59 68.95
Support Level $4.85 $10.50
Resistance Level N/A N/A
Average True Range (ATR) 0.35 0.01
MACD 0.12 0.00
Stochastic Oscillator 91.07 85.83

Price Performance

Historical Comparison
ABEO
DRDB

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

About DRDB Roman DBDR Acquisition Corp. II Ordinary shares

Roman DBDR Acquisition Corp II is a blank check company.

Share on Social Networks: